AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Pre-Outbreak Forecast CT Diagnosis Other Segment by Application Hospital Center for Infectious Diseases Other By Company Infervision BlueDot Yitu Healthcare SPHCC By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Pre-Outbreak Forecast 1.2.3 CT Diagnosis 1.2.4 Other 1.3 Market by Application 1.3.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Center for Infectious Diseases 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Perspective (2017-2028) 2.2 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Growth Trends by Region 2.2.1 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Historic Market Size by Region (2017-2022) 2.2.3 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecasted Market Size by Region (2023-2028) 2.3 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Dynamics 2.3.1 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Industry Trends 2.3.2 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Drivers 2.3.3 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Challenges 2.3.4 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Players by Revenue 3.1.1 Global Top AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Players by Revenue (2017-2022) 3.1.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Players (2017-2022) 3.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue 3.4 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Concentration Ratio 3.4.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue in 2021 3.5 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Key Players Head office and Area Served 3.6 Key Players AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Solution and Service 3.7 Date of Enter into AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market 3.8 Mergers & Acquisitions, Expansion Plans 4 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Breakdown Data by Type 4.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Historic Market Size by Type (2017-2022) 4.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecasted Market Size by Type (2023-2028) 5 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Breakdown Data by Application 5.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Historic Market Size by Application (2017-2022) 5.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size (2017-2028) 6.2 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type 6.2.1 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2017-2022) 6.2.2 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2023-2028) 6.2.3 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Type (2017-2028) 6.3 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application 6.3.1 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2017-2022) 6.3.2 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2023-2028) 6.3.3 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Application (2017-2028) 6.4 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country 6.4.1 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2017-2022) 6.4.2 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size (2017-2028) 7.2 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type 7.2.1 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2017-2022) 7.2.2 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2023-2028) 7.2.3 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Type (2017-2028) 7.3 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application 7.3.1 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2017-2022) 7.3.2 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2023-2028) 7.3.3 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Application (2017-2028) 7.4 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country 7.4.1 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2017-2022) 7.4.2 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size (2017-2028) 8.2 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type 8.2.1 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2017-2022) 8.2.2 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2023-2028) 8.2.3 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Type (2017-2028) 8.3 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application 8.3.1 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2017-2022) 8.3.2 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2023-2028) 8.3.3 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Application (2017-2028) 8.4 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region 8.4.1 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2017-2022) 8.4.2 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size (2017-2028) 9.2 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type 9.2.1 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2017-2022) 9.2.2 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2023-2028) 9.2.3 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Type (2017-2028) 9.3 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application 9.3.1 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2017-2022) 9.3.2 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2023-2028) 9.3.3 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Application (2017-2028) 9.4 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country 9.4.1 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2017-2022) 9.4.2 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size (2017-2028) 10.2 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type 10.2.1 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2017-2022) 10.2.2 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2023-2028) 10.2.3 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Type (2017-2028) 10.3 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application 10.3.1 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2017-2022) 10.3.2 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2023-2028) 10.3.3 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Application (2017-2028) 10.4 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country 10.4.1 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2017-2022) 10.4.2 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Infervision 11.1.1 Infervision Company Details 11.1.2 Infervision Business Overview 11.1.3 Infervision AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Introduction 11.1.4 Infervision Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2017-2022) 11.1.5 Infervision Recent Developments 11.2 BlueDot 11.2.1 BlueDot Company Details 11.2.2 BlueDot Business Overview 11.2.3 BlueDot AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Introduction 11.2.4 BlueDot Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2017-2022) 11.2.5 BlueDot Recent Developments 11.3 Yitu Healthcare 11.3.1 Yitu Healthcare Company Details 11.3.2 Yitu Healthcare Business Overview 11.3.3 Yitu Healthcare AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Introduction 11.3.4 Yitu Healthcare Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2017-2022) 11.3.5 Yitu Healthcare Recent Developments 11.4 SPHCC 11.4.1 SPHCC Company Details 11.4.2 SPHCC Business Overview 11.4.3 SPHCC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Introduction 11.4.4 SPHCC Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2017-2022) 11.4.5 SPHCC Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
List of Tables Table 1. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Pre-Outbreak Forecast Table 3. Key Players of CT Diagnosis Table 4. Key Players of Other Table 5. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2017-2022) & (US$ Million) Table 8. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Region (2017-2022) Table 9. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Region (2023-2028) Table 11. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Trends Table 12. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Drivers Table 13. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Challenges Table 14. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Restraints Table 15. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue by Players (2017-2022) & (US$ Million) Table 16. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Share by Players (2017-2022) Table 17. Global Top AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia as of 2021) Table 18. Ranking of Global Top AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Solution and Service Table 22. Date of Enter into AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2017-2022) & (US$ Million) Table 25. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Type (2017-2022) Table 26. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Type (2023-2028) Table 28. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2017-2022) & (US$ Million) Table 29. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Share by Application (2017-2022) Table 30. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Share by Application (2023-2028) Table 32. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2017-2022) & (US$ Million) Table 33. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2023-2028) & (US$ Million) Table 34. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2017-2022) & (US$ Million) Table 35. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2023-2028) & (US$ Million) Table 36. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2017-2022) & (US$ Million) Table 37. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2023-2028) & (US$ Million) Table 62. Infervision Company Details Table 63. Infervision Business Overview Table 64. Infervision AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Table 65. Infervision Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2017-2022) & (US$ Million) Table 66. Infervision Recent Developments Table 67. BlueDot Company Details Table 68. BlueDot Business Overview Table 69. BlueDot AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Table 70. BlueDot Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2017-2022) & (US$ Million) Table 71. BlueDot Recent Developments Table 72. Yitu Healthcare Company Details Table 73. Yitu Healthcare Business Overview Table 74. Yitu Healthcare AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Table 75. Yitu Healthcare Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2017-2022) & (US$ Million) Table 76. Yitu Healthcare Recent Developments Table 77. SPHCC Company Details Table 78. SPHCC Business Overview Table 79. SPHCC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Table 80. SPHCC Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2017-2022) & (US$ Million) Table 81. SPHCC Recent Developments Table 82. Research Programs/Design for This Report Table 83. Key Data Information from Secondary Sources Table 84. Key Data Information from Primary Sources List of Figures Figure 1. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Type: 2021 VS 2028 Figure 2. Pre-Outbreak Forecast Features Figure 3. CT Diagnosis Features Figure 4. Other Features Figure 5. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Application: 2021 VS 2028 Figure 6. Hospital Case Studies Figure 7. Center for Infectious Diseases Case Studies Figure 8. Other Case Studies Figure 9. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Report Years Considered Figure 10. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Region: 2021 VS 2028 Figure 13. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Players in 2021 Figure 14. Global Top AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia as of 2021) Figure 15. The Top 10 and 5 Players Market Share by AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue in 2021 Figure 16. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY (2017-2028) & (US$ Million) Figure 17. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2017-2028) Figure 18. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2017-2028) Figure 19. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Share by Country (2017-2028) Figure 20. United States AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY (2017-2028) & (US$ Million) Figure 23. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2017-2028) Figure 24. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2017-2028) Figure 25. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Share by Country (2017-2028) Figure 26. Germany AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. France AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. U.K. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Italy AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Russia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Nordic Countries AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY (2017-2028) & (US$ Million) Figure 33. Asia Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2017-2028) Figure 34. Asia Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2017-2028) Figure 35. Asia Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Share by Region (2017-2028) Figure 36. China AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Japan AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. South Korea AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Southeast Asia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. India AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Australia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 42. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY (2017-2028) & (US$ Million) Figure 43. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2017-2028) Figure 44. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2017-2028) Figure 45. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Share by Country (2017-2028) Figure 46. Mexico AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Brazil AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY (2017-2028) & (US$ Million) Figure 49. Middle East and Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2017-2028) Figure 50. Middle East and Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2017-2028) Figure 51. Middle East and Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Share by Country (2017-2028) Figure 52. Turkey AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Saudi Arabia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. UAE AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Infervision Revenue Growth Rate in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2017-2022) Figure 56. BlueDot Revenue Growth Rate in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2017-2022) Figure 57. Yitu Healthcare Revenue Growth Rate in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2017-2022) Figure 58. SPHCC Revenue Growth Rate in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2017-2022) Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed